Maria Ripps

CFO: new consumer AI-search and provider AI products are not material to revenue this year; 2026 is a testing and innovation period, mirroring the Smart Campaigns go-to-market rollout with carriers and agents.

CEO declined to guide H2, reiterated $1B in 2-3 years path unchanged. Q2 guide is continuation of Q1 momentum. No change in view since last discussion.

CEO said 15+ insurance ChatGPT apps exist but all shallow with high friction and minimal traffic. EverQuote building something more differentiated but not yet in production. Paid advertising via ChatGPT and content strategy expected to drive more meaningful scale.

CEO described three AI search vectors: content optimized for LLM training, technical integrations/apps within platforms, and programmatic advertising as platforms open paid channels. Q1 margins normalizing back to steady state from Q4 investments.

CEO reiterated $1B organic path: 3 years implies 13% annual growth, 2 years implies 20-21%. CFO said EBITDA margins to expand 100bps in 2026, implying at least 20% EBITDA dollar growth. Q2 expected flattish with Q1, implying 15-16% YoY growth reacceleration.

CEO highlighted Smart Campaigns model improvements, plans to extend AI bidding to local agents in 2026, and AI voice integration in call workflows achieving good performance levels.

CEO said carrier spend still lagging profitability trends. 80% of top 25 below peak spend. One major carrier reactivating in Q4. Soft market cycles last 5+ years and company is in early stages.

CEO said carriers showing 80s combined ratios with no anticipated budget constraints or pullback. All recent carrier interactions focused entirely on growth.

CEO acknowledged insurance search will evolve but noted insurance opacity and regulation may slow shift. Building LLM-based conversational workflows to position for AI traffic acquisition.

CEO said most competitors reverted to pre-one-to-one state. EverQuote retained select changes around exclusivity that improve lead quality, maintaining competitive advantage.

CEO noted carriers overshooting profitability targets, creating cushion against tariff-driven loss pressure. CFO reiterated growth normalization in H2 against tougher comps, with tariff impact still being monitored.

Steve framed the broadening as a durable soft-market cycle and attributed gating factors to carrier direct-to-consumer capability; answered directly.

Steve said LLM referral traffic keeps scaling and is higher quality than Google Organic, but overall marketplace impact is still relatively small; direct.

Steve argued peak underwriting profitability signals the start of the soft cycle, which historically lasts 5 to 7 years, supporting years of ad-spend growth.

Steve focused on the long-term Medicare Advantage opportunity while Pat said Q4 approximates the new under-65 baseline with comps normalizing by mid-2026.

Steve was very optimistic on carrier budgets, citing strong combined ratios and growing consensus that tariff inflation is manageable.

Steve Yi said the settlement sets a new under-65 baseline with no material impact on Medicare or P&C, and sees continued opportunity to serve consumers.

Steve explained the private marketplace is built for the largest publishers contracting directly with the largest advertisers; Pat added the open/private mix is vertical-specific.

Steve Yi gave an extended answer on strong carrier profitability, broadening demand, and manageable tariff impact.

Yemi said retention is in line with expectations and the weight category was much stronger than expected, giving conviction to raise guidance; qualitative, no retention metric quantified.

Andrew addressed the transition qualitatively (almost all new business now branded, many transitioned) but gave no specific transition portion or retention figure.

Andrew pointed to breadth of weight-loss assortment and a $100M run-rate reached pre-compounding to argue the category is durable even without compounded GLP-1s.

Okupe said scaling and verticalization let HIMS pass savings to subscribers, and lower GLP-1 price points expand the addressable audience with early promising signs.

Yemi attributed the QoQ softness to GLP-1 offboarding of commercial dosages and the deliberate sexual-health on-demand rotation, with other specialties growing 55%+.

Andrew described the shift to sticky daily multi-condition care (now ~40% of sexual health) but gave no specific timing for normalization; partial.

Andrew explained the medical intake, side-effect sensitivity assessment and provider/MedMatch role in personalizing dosing, a direct, substantive answer.

Alex cited continued ad-stack progress; Christian reiterated the second-half 2026 inflection but offered no specific mechanism for the margin turn.

Alex said a lower-price ad-inclusive tier adds little incrementality given premium already meets expectations, though he didn't rule it out long term.

Gustav said premium video podcasts now run without dynamic ad interruptions, with creators paid instead; no audio plans yet.